News
Research Roundup
Debbie Rigby takes a look at the latest in research news The 2023 Practitioner’s Toolkit for Managing Menopause This updated toolkit provides algorithms that guide the clinical assessment and care …
Oral corticosteroids—not always forever
Pharmacists conducting comprehensive medication reviews need to take a best possible medication history to identify long-term and cumulative use of oral corticosteroids, recommend medications to optimise underlying conditions, identify other …
The importance and skill of saying no
When a pharmacist is unable to fulfil a patient’s request for a particular medicine or service based on their professional opinion and legal and ethical obligations, it is important that …
Multimorbidity
Patients with complex multimorbidity experience a substantial burden not only because of their chronic health problems but also as a result of the treatments they receive. Multimorbidity also poses problems …
Sports supplements: the role of pharmacists in ensuring safe supplementation
By providing education, guidance and information, pharmacists can play a role in ensuring all purchasers of sport supplements—athletes, their parents, partners or carers—know how to use them safely, writes Karen …
Vaping: e-cigarettes in smoking cessation
What is the evidence for nicotine vaping products in smoking cessation and their impact on health more generally? By Sandra Rackemann BPharm (Hons), AACPA, Professional Development Pharmacist, Australasian College of …
Promoting healthy bones and preventing falls
Greater awareness of the risk factors for osteoporosis may help encourage early intervention and reduce fracture rates, writes Leanne Philpott Osteoporosis often goes undiagnosed until the first fracture occurs Discussing …
Keeping up with the news
Sign up now to receive our dedicated Hospital + Consultant Pharmacy newsletter The AJP Select Hospital + Consultant Pharmacy newsletter is now being sent only to those who have selected …
Oral semaglutide as effective as injectable
Ozempic/Wegovy sponsor trumpets results of Phase III clinical trial as its halts US ads A trial of an oral version of Novo Nordisk’s obesity and diabetes medication semaglutide, the active …
‘We don’t realise how valuable pharmacists are’
Double dispensing decision leaves doctor “flabbergasted” Labor’s plan to introduce 60-day dispensing will have significant unintended consequences, a former Assistant Health Minister warns. Speaking in the House of Representatives on …
Pharmacy figures rocket up Rich List
Chemist Warehouse and Apotex bosses all fare much better in new Fin Review wealth ranking The richest people in pharmacy have seen a sharp reversal of their fortunes upwards in …
Guild seeks ‘sensible way forward’ on double dispensing
Community pharmacists are being urged to “keep the pressure on the government” to limit the adverse impacts of 60-day dispensing Government officials need to restart negotiations with community pharmacy leaders …